Childhood Cerebral Adrenoleukodystrophy

Source: Pixabay.com

A Study Will Look at the Effects of an Experimental Drug on Childhood Cerebral ALD

Post author:Patient Worthy Contributor
Post published:August 7, 2018
Post category:Adrenoleukodystrophy

A Phase 1/2 clinical trial of the experimental drug NV1205 in patients with childhood cerebral adrenoleukodystrophy (CCALD) has been initiated, announced NeuroVia Inc. The source article can be found here,…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More